Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 15, No. 4, 2016, pp. 695-699
Bioline Code: pr16092
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 15, No. 4, 2016, pp. 695-699
© Copyright 2016 - Tropical Journal of Pharmaceutical Research
Effect of recombinant human erythropoietin expressions of apoptosis genes in rats following traumatic brain injury|
Yuan, Xuesong; Bian, Xiaoxing; Wei, Wenfeng; Tang, Yin & Bao, Qing
To explore the effect of recombinant human erythropoietin (r-HuEPO) on apoptosis in rats
after traumatic brain injury.
A total of 48 traumatic brain-injured Sprague Dawley (SD) rats were obtained by improved
Feeney’s traumatic brain injury model, and were randomly divided into four groups: normal salinetreated
rats (control) and rats treated with r-HuEPO at doses of 1000 U/kg, 3000 U/kg and 5000 U/kg.
Brain tissues were collected on the 7th day after trauma surgery. Apoptotic cells, and NF-kappa B (NFĸB)-,
c-myc-, and Fas/Fasl-positive cells were identified in brain tissues by immunohistochemical assay.
After treatment with r-HuEPO (3000 and 5000 U/kg), expression of NF-κB and Fas/Fasl were
significantly decreased (p < 0.05) compared to control rats, especially at the 5000 U/kg dose (p < 0.01).
However, for c-myc, no significant difference was observed between r-HuEPO treatment and control
groups (p > 0.05). Compared to the 1000 U/kg r-HuEPO group, Fas/Fasl expression levels were
significantly lower in the 3000 and 5000 U/kg r-HuEPO groups (p < 0.05). Additionally, expression of
NF-κB and Fasl in the 5000 U/kg r-HuEPO group was significantly lower than that in the 3000 U/kg r-
HuEPO group (p < 0.05). Moreover, the number of apoptotic cells in the r-HuEPO group (5000 U/kg)
was significantly lower than in the control group (p < 0.05).
Thus, r-HuEPO may be beneficial for treating traumatic brain injury via inhibition of NFkappa
B and Fas/Fasl expressions.
Recombinant human erythropoietin; Traumatic brain injury; Neuronal damage; NF-kappa B; Apoptosis; Fas/Fasl expression
Alternative site location: http://www.tjpr.org